Clinical trial
Leucovorin for the Treatment of 5 q Minus Syndrome
NCT00004997 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00004997 |
|---|---|
| Title | Leucovorin for the Treatment of 5 q Minus Syndrome |
| Official title | The Experimental Treatment of Transfusion Dependent 5q Minus Syndrome With Leucovorin |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | 5q Minus Syndrome, Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | Leucovorin |
| Enrollment | 14 |
| Start date | Apr 1, 1998 |
| Completion | Jul 1, 2002 |
| First posted | Mar 23, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: